Mersana Therapeutics's total assets for Q1 2025 were $112.47M, a decrease of -22.25% from the previous quarter. MRSN total liabilities were $143.34M for the fiscal quarter, a -7.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.